NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

First human trial of monoclonal antibody to prevent malaria opens

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. ...

page 11 from 40